Intranasal Dexmedetomidine and Perioperative Myocardial Injury

A phase 4 trial registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 140 participants.

Also called NCT07549282

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose prevention
Phase
Phase 4
Enrolled
  • 140 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT07549282
Planned start
(anticipated) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
China (from the registry)
Registry status
  • Not yet recruiting (from the registry)

Technical summary

Registry record NCT07549282. Randomized; quadruple masking; primary purpose prevention. Start 2026-08 (anticipated); primary completion 2027-01 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Intranasal Dexmedetomidine and Perioperative Myocardial Injury
Condition
Coronary Heart Disease
Condition
Myocardial Injury
Condition
Dexmedetomidine
Intervention (Drug)
Intranasal Dexmedetomidine
Intervention (Drug)
Normal saline
Lead sponsor
Second Affiliated Hospital, Zhejiang University, School of Medicine (class: other)

Record details

Record id
cardio:ct-nct07549282
Content hash
bf62ade2ff2b98b98bb6f69ce8df48ce3760cf256fd8d259f15abc7f52e271a2